You searched for "Oculus"
In conversation with Captain Tyson J Brunstetter
We chat to keynote speaker Captain Tyson J Brunstetter about how Spaceflight Associated Neuro-ocular Syndrome (SANS) research is progressing at the Heidelberg Engineering SPECTRALIS® Masterclass event in Glasgow, May 2019. Click the images below to see his answers to our...Stephen Connell joins Birmingham Optical Ophthalmology division as Clinical Sales Specialist
Stephen began his career in Ophthalmology in 2006 as an Ophthalmic Science Practitioner joining the Royal Hallamshire Hospital.My Top Five: A foundation doctor’s top five misconceptions about ophthalmology
Choosing a specialty is challenging. As a foundation doctor, it often feels as if this choice is based solely on fleeting experiences. Compared to other specialties, there is relatively little exposure to ophthalmology during either medical school or foundation years....Moorfields Hot topics in comprehensive ophthalmology
Moorfields Education Hot topics in comprehensive ophthalmology
Effect of intra-arterial chemotherapy drug regimens on globe salvage outcomes of retinoblastoma patients
This is a retrospective study from Shandong University, China, between May 2016 to November 2019, to compare the effect of 3-drug regimen (melphalan (MP) , topotecan (TP) and Carboplatin (CP)) of 95 patients (97 eyes) with two-drug regimen (MP and...
Use of immunomodulatory treatment for non-infectious uveitis: an International
Two-hundred-and-twenty-one group members from 53 countries completed a questionnaire on their indications, investigations and use of conventional and biologics and follow-up of treated patients. Main indications to start systemic immunomodulatory drugs were: uveitis not controlled by oral prednisolone (94.1%), specific...
Three-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial
This was a placebo-controlled, double-blind, randomised clinical trial of 97 children to examine the safety and efficacy of low-dose atropine (0.1% and 0.01% loading dose) after 2-year treatment and 1-year washout in 6–12-year-old Danish children with myopia. Ninety-one children were...
